New daily pill offers rare hope in advanced pancreatic cancer

Jun 10, 2026 | 18:26 IST

A once-daily experimental pill nearly doubled median survival in advanced pancreatic cancer in a global trial. It is not a cure or yet approved in India, but doctors say it marks a rare advance against one of the hardest cancers to treat

For patients with advanced pancreatic cancer, extra time is often hard won. A new once-daily experimental pill has now shown it can nearly double median survival compared with chemotherapy in a major global trial.

TOI

TOI

New daily pill offers rare hope in advanced pancreatic cancer

A once-daily experimental pill nearly doubled median survival in advanced pancreatic cancer in a global trial. It is not a cure or yet approved in India, but doctors say it marks a rare advance against one of the hardest cancers to treat

{{{h1}}}

{{{h1}}}

{{{h3}}}

{{{offerprice}}}

{{{h3}}}

{{{offerprice}}}

{{{h1}}}

{{{h1}}}

{{{h1}}}

{{h2}}

{{{h1}}}

{{h2}}

{{{h1}}}

{{h2}}

Your Privacy is Important to us

Opt out of the sale or sharing of personal information

TOI

New daily pill offers rare hope in advanced pancreatic cancer

A once-daily experimental pill nearly doubled median survival in advanced pancreatic cancer in a global trial. It is not a cure or yet approved in India, but doctors say it marks a rare advance against one of the hardest cancers to treat

{{{h1}}}

{{{h1}}}

{{{h3}}}

{{{offerprice}}}

{{{h3}}}

{{{offerprice}}}

{{{h1}}}

{{{h1}}}

{{{h1}}}

{{h2}}

{{{h1}}}

{{h2}}

{{{h1}}}

{{h2}}